Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.

By Janet L. Stanford, Ziding Feng, A. Hamilton, Frank D. Gilliland, R. Stephenson, J. Eley, P. Albertsen, L. Harlan, A. Potosky. Journal of the American Medical Association (JAMA), 2000

1,222 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/bbbce27685f31ab6934407f28e4065e05a079744

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. E. Stovall
2. S. Greenfield
3. M. Hewitt

In Pulmonary and Respiratory Medicine

1. S. Greenfield
2. E. Stovall
3. S. Lippman
4. M. Hewitt
5. Celestia S. Higano
6. M. Hallek

Citations in the corpus

• From cancer patient to cancer survivor : lost in transition (2006, background): “In one study, 42 percent of men reported that their sexual function was a moderate to big problem at 2 years following radical prostatectomy (Stanford et al., 2000).”
• Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 (2018, neutral): “Hodgkin lymphoma 73 (66-82) 45 (40-54) 28 (25-32) 1.”
• Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) (2008, methodology): “PSA velocity 12 (3) 10 (2) 13 (3) 16 (4)”
• Guideline for the management of clinically localized prostate cancer: 2007 update. (2007, background): “Erectile dysfunction rates in some surgical series are as high as 60% to 90% one or more years following treatment.(76,79,83,93) Nerve-sparing procedures appear to result in preserved function for many men, though selection factors may bias the results of some of the early studies of this technique ”